{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/fibroids/","result":{"data":{"firstChapter":{"id":"17b509af-8275-5623-a47b-ec3301ad1e00","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field bf2717fb-e761-4c8d-82e0-99f57771a22c --><h1>Fibroids: Summary</h1><!-- end field bf2717fb-e761-4c8d-82e0-99f57771a22c -->","htmlStringContent":"<!-- begin item f723d230-30ce-4fc2-92b1-53a92b719154 --><!-- begin field 1737cb88-aa3e-4065-a281-033e932c72b0 --><ul><li>Uterine fibroids are the most common benign tumour in women — they are a mixture of smooth muscle cells and fibroblasts, which form hard, round, whorled tumours in the myometrium.<ul><li>They develop in women of reproductive age and are promoted and maintained by exposure to oestrogen and progestogen.</li><li>They can be single, or multiple, and their size varies from a few millimetres to 30 cm or larger.</li></ul></li><li>After puberty, the prevalence of fibroids increases with age until the menopause.</li><li>Risk factors include:<ul><li>Increasing age.</li><li>Early puberty.</li><li>Obesity.</li><li>Black ethnicity.</li><li>Family history.</li></ul></li><li>Fibroids are commonly asymptomatic and may be identified incidentally by examination or investigation for gynaecological problems (such as failure to conceive) or during a routine pregnancy assessment.</li><li>Symptoms of fibroids include:<ul><li>Heavy menstrual bleeding.</li><li>Pelvic pain.</li><li>Secondary dysmenorrhoea.</li><li>Urinary tract problems such as frequency, urgency, urinary incontinence, or hydronephrosis.</li><li>Non-specific bowel problems, such as bloating or constipation.</li></ul></li><li>Assessment of women with suspected fibroids should include:<ul><li>A detailed medical and gynaecological history.</li><li>An abdominal and a bimanual pelvic examination.</li></ul></li><li>On pelvic examination:<ul><li>A firm, enlarged, and irregularly shaped non-tender uterus is characteristic of uterine fibroids.</li><li>The mass can be moved slightly from side-to-side.</li></ul></li><li>The diagnosis should be confirmed and more serious causes of the woman's symptoms and signs (such as cancer) excluded.<ul><li>A routine ultrasound scan (transabdominal and transvaginal) should be arranged for women with typical features of uterine fibroids and no features of cancer.</li><li>Women with ascites and/or a pelvic or abdominal mass (which is not obviously due to uterine fibroids) should be referred urgently.</li><li>Women with a pelvic mass associated with any other features of cancer (such as unexplained bleeding, or weight loss) should be referred using a suspected cancer pathway referral (for an appointment within 2 weeks)<strong>.</strong></li></ul></li><li>Women should also be referred if they have: <ul><li>Complications, such as compressive symptoms from large fibroids (for example dyspareunia, pelvic pain or discomfort, constipation, or urinary symptoms).</li><li>Fertility or obstetric problems associated with fibroids.</li><li>A clinical or radiological suspicion of malignancy.</li><li>Fibroids which are palpable abdominally, or intracavity fibroids and/or whose uterine length is measured at ultrasound, or hysteroscopy, greater than 12 cm.</li></ul></li></ul><!-- end field 1737cb88-aa3e-4065-a281-033e932c72b0 --><!-- end item f723d230-30ce-4fc2-92b1-53a92b719154 -->","topic":{"id":"6463a640-e4df-5049-8bb4-6654ab8b15ce","topicId":"3fd67974-f2c5-44ed-822f-084a7bfa2b77","topicName":"Fibroids","slug":"fibroids","aliases":[],"chapters":[{"id":"17b509af-8275-5623-a47b-ec3301ad1e00","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"dd45c961-3e46-592b-93bd-04eac254ce78","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"cc8303eb-62bc-5f8f-b697-83157c2c4fe7","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"f79d0226-1517-5e54-aab7-8835d760b8cc","slug":"changes","fullItemName":"Changes"},{"id":"767a9892-20df-5979-bed9-cffded6848c6","slug":"update","fullItemName":"Update"}]},{"id":"7b24582e-8917-5b59-a8bf-73b8769a2e86","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"96c90f71-050c-59fa-aedc-953048783302","slug":"goals","fullItemName":"Goals"},{"id":"e4a2aeb9-62f9-58bb-a248-c1dc9358b254","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1666f790-8ff1-5ba8-95de-23a735364bc8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f35cbfa6-b4fc-574b-8eb6-7df9e8070976","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c597adf8-a842-51ae-88e6-441cacfbdfc9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f1a497a7-9324-5e43-bc01-3b33e344ff83","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"18d5fa10-3213-5357-9062-7b0e16a0a785","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"38f26131-0aa0-5700-a6fd-25bd7a26503a","slug":"definition","fullItemName":"Definition"},{"id":"ee0338f8-7167-58f0-8c50-1aab97a3b27e","slug":"prevalence","fullItemName":"Prevalence"},{"id":"709492e8-0053-5ca6-8a20-ddfabff85694","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"b7f5350a-2c61-535b-bb44-cd9c51132b57","slug":"natural-history-of-fibroids","fullItemName":"Natural history of fibroids"},{"id":"e3765a3b-c1e7-5221-acb7-cc000b1de1c5","slug":"complications","fullItemName":"Complications"}]},{"id":"3c5ed9b8-5b6d-5b68-8d15-b9e7b15a8d1d","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"b98686e1-b4a2-5937-9e77-a1aa76faec11","slug":"assessment","fullItemName":"Assessment"},{"id":"137f352c-c6be-56ed-bfaf-8627d692a159","slug":"signs-symptoms","fullItemName":"Signs and symptoms"},{"id":"0a19e969-b9fc-5a47-99d1-f81fa33bfcc2","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"26643766-7cf9-532d-8dc9-a1ca4a679b5c","slug":"management","fullItemName":"Management","subChapters":[{"id":"0dcebc15-0b4a-5898-9e9d-bdce5879ed3d","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"16c07bd4-71e3-573e-a85f-190156235c98","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"4bbe6ec3-6612-56ee-bd5d-3bac8fc870aa","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"eec2e9fc-14b3-52df-b3f8-853d2bd020c1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f9855d83-db65-5e68-b06a-bfd8533e2b6b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8a30e797-0317-501c-96a6-0c96f08d306e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"94bd4428-5492-5e06-854c-3f6747917258","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"41c7124d-fd7d-5771-9ef3-cff4588a2f3b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a166d27d-9883-5200-a62f-532b916906ea","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"6463a640-e4df-5049-8bb4-6654ab8b15ce","topicId":"3fd67974-f2c5-44ed-822f-084a7bfa2b77","topicName":"Fibroids","slug":"fibroids","aliases":[],"topicSummary":"Uterine fibroids are the most common benign tumour in women  they are a mixture of smooth muscle cells and fibroblasts,","lastRevised":"Last revised in December 2018","nextPlannedReviewBy":"2022-07-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2022-06","nextPlannedReviewByDisplay":"June 2022","specialities":[{"id":"0c813417-9691-5826-9371-c4bec6c53f06","name":"Women's health","slug":"womens-health"}],"chapters":[{"id":"17b509af-8275-5623-a47b-ec3301ad1e00","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"dd45c961-3e46-592b-93bd-04eac254ce78","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"cc8303eb-62bc-5f8f-b697-83157c2c4fe7","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"f79d0226-1517-5e54-aab7-8835d760b8cc","slug":"changes","fullItemName":"Changes"},{"id":"767a9892-20df-5979-bed9-cffded6848c6","slug":"update","fullItemName":"Update"}]},{"id":"7b24582e-8917-5b59-a8bf-73b8769a2e86","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"96c90f71-050c-59fa-aedc-953048783302","slug":"goals","fullItemName":"Goals"},{"id":"e4a2aeb9-62f9-58bb-a248-c1dc9358b254","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1666f790-8ff1-5ba8-95de-23a735364bc8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f35cbfa6-b4fc-574b-8eb6-7df9e8070976","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c597adf8-a842-51ae-88e6-441cacfbdfc9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f1a497a7-9324-5e43-bc01-3b33e344ff83","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"18d5fa10-3213-5357-9062-7b0e16a0a785","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"38f26131-0aa0-5700-a6fd-25bd7a26503a","slug":"definition","fullItemName":"Definition"},{"id":"ee0338f8-7167-58f0-8c50-1aab97a3b27e","slug":"prevalence","fullItemName":"Prevalence"},{"id":"709492e8-0053-5ca6-8a20-ddfabff85694","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"b7f5350a-2c61-535b-bb44-cd9c51132b57","slug":"natural-history-of-fibroids","fullItemName":"Natural history of fibroids"},{"id":"e3765a3b-c1e7-5221-acb7-cc000b1de1c5","slug":"complications","fullItemName":"Complications"}]},{"id":"3c5ed9b8-5b6d-5b68-8d15-b9e7b15a8d1d","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"b98686e1-b4a2-5937-9e77-a1aa76faec11","slug":"assessment","fullItemName":"Assessment"},{"id":"137f352c-c6be-56ed-bfaf-8627d692a159","slug":"signs-symptoms","fullItemName":"Signs and symptoms"},{"id":"0a19e969-b9fc-5a47-99d1-f81fa33bfcc2","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"26643766-7cf9-532d-8dc9-a1ca4a679b5c","slug":"management","fullItemName":"Management","subChapters":[{"id":"0dcebc15-0b4a-5898-9e9d-bdce5879ed3d","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"16c07bd4-71e3-573e-a85f-190156235c98","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"4bbe6ec3-6612-56ee-bd5d-3bac8fc870aa","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"eec2e9fc-14b3-52df-b3f8-853d2bd020c1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f9855d83-db65-5e68-b06a-bfd8533e2b6b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8a30e797-0317-501c-96a6-0c96f08d306e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"94bd4428-5492-5e06-854c-3f6747917258","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"41c7124d-fd7d-5771-9ef3-cff4588a2f3b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a166d27d-9883-5200-a62f-532b916906ea","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"6463a640-e4df-5049-8bb4-6654ab8b15ce"}},"staticQueryHashes":["3666801979"]}